Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent consecutive partial molar pregnancy.

H Narayan1, P Mansour, W W McDougall

  • 1Department of Obstetrics & Gynaecology, University of Leicester, Leicester Royal Infirmary, UK.

Gynecologic Oncology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.

Peptides·2012
Same author

Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.

Clinical and laboratory haematology·2005
Same author

Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy.

Spinal cord·2005
Same author

Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis.

Spinal cord·2004
Same author

Pseudo-tumours of the urinary tract in patients with spinal cord injury/spina bifida.

Spinal cord·2004
Same author

Milk of calcium in urethral diverticulum in a male patient with paraplegia and suprapubic urinary drainage.

Spinal cord·2004
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Recurrent partial hydatidiform moles are rare but can have serious implications. This case highlights a patient with four consecutive partial moles and severe thyrotoxicosis, emphasizing the need for close monitoring.

Area of Science:

  • Reproductive Medicine
  • Gynecologic Oncology

Background:

  • Gestational trophoblastic disease (GTD) is a rare pregnancy complication.
  • Recurrent GTD, though infrequent (0.6-2.6%), carries significant clinicopathological implications, including risks of malignancy and impaired reproductive outcomes.

Observation:

  • This report details an unusual case of a patient experiencing four consecutive recurrent partial hydatidiform moles.
  • The patient's third molar pregnancy was complicated by severe thyrotoxicosis, indicating a progressively aggressive clinical course.

Findings:

  • Partial hydatidiform moles are known to recur, but recurrent cases are poorly documented in medical literature.
  • The cytogenetics and histopathology of complete and partial moles differ, yet share clinicopathological similarities.

Related Experiment Videos

Implications:

  • This case underscores the rare but significant risk of malignant sequelae associated with recurrent GTD.
  • Close endocrinological monitoring is crucial for patients with recurrent molar pregnancies due to potential complications like thyrotoxicosis.